Lipid Standards

LIPID MAPS® analytical standards include

  • MS/MS spectra, including annotations for principal product ions
  • Experimental parameters used for acquisition of MS/MS spectra
  • LC retention time data for Eicosanoids
  • Links to Cayman/Avanti catalog product descriptions
  • Literature reference(s) pertaining to identification of MS product ions

 

View standards by lipid category

 

Search:

  Records per page     

Fields searched:
Name, Systematic Name (case insensitive)


This table can be scrolled horizontally if width exceeds container width.

LM ID
Name
Systematic Name
Cayman ID
Avanti ID
MS/MS
Ion
Conditions
LMPR03080001 Dolichyl-19 phosphate a-dihydrononadecaprenyl phosphate Spectrum [M-H]- Details
LMPR03030002 Undecaprenyl diphosphate-
GlcNAc-ManNAcA
ManNAcAbeta1-4GlcNAcalpha-undecaprenyl diphosphate Spectrum [M-H]- Details
LMSL02000001 Kdo2-lipid A Kdo2-lipid A Spectrum [M-2H]2- Details
LMGP09010001 PIP3[3',4',5'](17:0/20:4(5Z,
8Z,11Z,14Z))
1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-3',4',5'-trisphosphate) LM1906 Spectrum [M-H]- Details
LMGP04090002 54:3 SLBPA 2,3-di-(9Z-octadecenoyl)-sn-glycero-1-phospho-(2'-lyso-3'-(9Z-octadecenoyl)-1'-sn-glycerol) Spectrum [M-H]- Details
LMGP08010002 PIP2[3',5'](17:0/20:4(5Z,8Z,
11Z,14Z))
1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-3',5'-bisphosphate) LM1905 Spectrum [M-H]- Details
LMGP08010001 PIP2[3',4'](17:0/20:4(5Z,8Z,
11Z,14Z))
1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-3',4'-bisphosphate) LM1903 Spectrum [M-H]- Details
LMGP08010003 PIP2[4',5'](17:0/20:4(5Z,8Z,
11Z,14Z))
1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-4',5'-bisphosphate) LM1904 Spectrum [M-H]- Details
LMSL01020002 UDP-2,3-diacyl-GlcN UDP-2,3-bis-(3R-hydroxy-tetradecanoyl)-alphaD-glucosamine Spectrum [M-H]- Details
LMPR03020002 Undecaprenyl phosphate
mannose
Alpha-mannosyl-undecaprenyl phosphate Spectrum [M-H]- Details
LMGP13010004 CDP-DG(18:1(9Z)/18:1(9Z)) 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-cytidine-5'-diphosphate Spectrum [M+H]+ Details
LMGP13010004 CDP-DG(18:1(9Z)/18:1(9Z)) 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-cytidine-5'-diphosphate Spectrum [M-H]- Details
LMGP13010004 CDP-DG(18:1(9Z)/18:1(9Z)) 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-cytidine-5'-diphosphate Spectrum [M-H]- Details
LMGP13010004 CDP-DG(18:1(9Z)/18:1(9Z)) 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-cytidine-5'-diphosphate Spectrum [M-H]- Details
LMPR03030003 Lipid II GlcNAcbeta1-4MurNAc-(L-Ala-gamma-D-Glu-A2pm-D-Ala-D-Ala)-alpha-undecaprenyl diphosphate Spectrum [M-2H]2- Details
LMGP13010003 CDP-DG(16:0/16:0) 1,2-dihexadecanoyl-sn-glycero-3-cytidine-5'-diphosphate Spectrum [M+H]+ Details
LMGP13010003 CDP-DG(16:0/16:0) 1,2-dihexadecanoyl-sn-glycero-3-cytidine-5'-diphosphate Spectrum [M-H]- Details
LMGP13010003 CDP-DG(16:0/16:0) 1,2-dihexadecanoyl-sn-glycero-3-cytidine-5'-diphosphate Spectrum [M-H]- Details
LMGP13010003 CDP-DG(16:0/16:0) 1,2-dihexadecanoyl-sn-glycero-3-cytidine-5'-diphosphate Spectrum [M-H]- Details
LMGP07010002 PIP[3'](17:0/20:4(5Z,8Z,11Z,
14Z))
1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-3'-phosphate) LM1900 Spectrum [M-H]- Details
LMGP06010005 PI(21:0/22:6(4Z,7Z,10Z,13Z,
16Z,19Z))
1-heneicosanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phospho-(1'-myo-inositol) LM1503 Spectrum [M-H]- Details
LMGP07010003 PIP[4'](17:0/20:4(5Z,8Z,11Z,
14Z))
1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-4'-phosphate) LM1901 Spectrum [M-H]- Details
LMGP07010004 PIP[5'](17:0/20:4(5Z,8Z,11Z,
14Z))
1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-5'-phosphate) LM1902 Spectrum [M-H]- Details
LMGP01011110 PC(22:1(13Z)/22:1(13Z)) 1,2-di-(13Z-docosenoyl)-sn-glycero-3-phosphocholine 25728 Spectrum [M.Cl]- Details
LMGP01010004 PC(21:0/22:6(4Z,7Z,10Z,13Z,
16Z,19Z))
1-heneicosanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine LM1003 Spectrum [M.Cl]- Details
LMGP01011110 PC(22:1(13Z)/22:1(13Z)) 1,2-di-(13Z-docosenoyl)-sn-glycero-3-phosphocholine 25728 Spectrum [M+H]+ Details
LMGP06010010 PI(18:0/20:4(5Z,8Z,11Z,14Z)) 1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol) Spectrum [M-H]- Details
LMPR02010001 Coenzyme Q10 11506 Spectrum [M+NH4]+ Details
LMGP01010004 PC(21:0/22:6(4Z,7Z,10Z,13Z,
16Z,19Z))
1-heneicosanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine LM1003 Spectrum [M+H]+ Details
LMGP03010004 PS(21:0/22:6(4Z,7Z,10Z,13Z,
16Z,19Z))
1-heneicosanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoserine Spectrum [M-H]- Details
LMGP06010004 PI(17:0/20:4(5Z,8Z,11Z,14Z)) 1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol) LM1502 Spectrum [M-H]- Details
LMGP01010821 PC(18:0/22:6(4Z,7Z,10Z,13Z,
16Z,19Z))
1-octadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine 25595 Spectrum [M.Cl]- Details
LMGP06010008 PI(18:0/18:0) 1,2-dioctadecanoyl-sn-glycero-3-phospho-(1'-myo-inositol) Spectrum [M-H]- Details
LMGP04010004 PG(21:0/22:6(4Z,7Z,10Z,13Z,
16Z,19Z))
1-heneicosanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexenoyl)-sn-glycero-3-phospho-(1'-rac-glycerol) Spectrum [M-H]- Details
LMGP01030014 PC(P-18:0/22:6(4Z,7Z,10Z,13Z,
16Z,19Z))
1-(1Z-octadecenyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine Spectrum [M.Cl]- Details
LMGP01011014 PC(20:0/20:0) 1,2-dieicosanoyl-sn-glycero-3-phosphocholine 15096 Spectrum [M.Cl]- Details
LMPR03020001 undecaprenyl phosphate 3,7,11,15,19,23,27,31,35,39,43-undecamethyltetratetraconta-2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E,38E,42-undecaen-1-yl phosphate Spectrum [M-H]- Details
LMGP01010802 PC(18:0/20:4(5Z,8Z,11Z,14Z)) 1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphocholine 10009864 Spectrum [M.Cl]- Details
LMGP03010040 PS(18:0/22:6(4Z,7Z,10Z,13Z,
16Z,19Z))
1-octadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoserine Spectrum [M+H]+ Details
LMGP03010040 PS(18:0/22:6(4Z,7Z,10Z,13Z,
16Z,19Z))
1-octadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoserine Spectrum [M-H]- Details
LMGP02010004 PE(21:0/22:6(4Z,7Z,10Z,13Z,
16Z,19Z))
1-heneicosanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine LM1003 Spectrum [M+H]+ Details
LMGP01010821 PC(18:0/22:6(4Z,7Z,10Z,13Z,
16Z,19Z))
1-octadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine 25595 Spectrum [M+H]+ Details
LMGP02010004 PE(21:0/22:6(4Z,7Z,10Z,13Z,
16Z,19Z))
1-heneicosanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine LM1003 Spectrum [M-H]- Details
LMGP01010003 PC(17:0/20:4(5Z,8Z,11Z,14Z)) 1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphocholine LM1002 Spectrum [M.Cl]- Details
LMGP01030012 PC(P-18:0/20:4(5Z,8Z,11Z,14Z)
)
1-(1Z-octadecenyl)-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphocholine Spectrum [M.Cl]- Details
LMGL03010001 TG(16:0/16:0/16:0) 1,2,3-trihexadecanoyl-sn-glycerol 23334 Spectrum [M+NH4]+ Details
LMGP04010040 PG(18:0/22:6(4Z,7Z,10Z,13Z,
16Z,19Z))
1-octadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phospho-(1'-sn-glycerol) Spectrum [M-H]- Details
LMGP01010890 PC(18:1(9Z)/18:1(9Z)) 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine 15098 Spectrum [M.Cl]- Details
LMGP01030014 PC(P-18:0/22:6(4Z,7Z,10Z,13Z,
16Z,19Z))
1-(1Z-octadecenyl)-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine Spectrum [M+H]+ Details
LMGP01011014 PC(20:0/20:0) 1,2-dieicosanoyl-sn-glycero-3-phosphocholine 15096 Spectrum [M+H]+ Details

Number of records: 481

next 50 records